Webinar: How late 2017 has changed medtech

Share

This webinar was presented live on Wednesday, October 11, 2017. Click below to watch on demand.

 

 

 

When it comes to news out of the U.S. government: one word could sum up what it means for the medical device industry: “uncertainty.”

It was true at the start of 2017. And it is even truer today.

The effort to repeal and replace the Affordable Care Act is dead for now, a permanent repeal of the medical device tax is unclear, and FDA fee hikes taking effect Oct. 1 could affect innovation in surprising ways. Meanwhile, major M&A deals continue, with Stryker making a $701 million fluorescence imaging technology play with its acquisition of Novadaq.

 

Featured Speaker:

 

Chris Newmarker
Managing Editor
Medical Design & Outsourcing

 

 

 

 

 

Last Chance to Save for DeviceTalks Boston!

textadimage Early rates for DeviceTalks Boston end August 15th.

Don't miss the chance to save $100 and join top medtech innovators including leaders from Hologic, Google, Gray Matter, TransEnterix, NxStage Medical, Smith & Nephew, HeartFlow, Dynatronics, Johnson & Johnson, Allied Minds, and many more.

View Full Agenda

Register today to save. Use code LASTCALL to save an additional 10%.

Speak Your Mind

*